Scientific Formal (Paper) Presentations pdf
Gastrointestinal (Hepatocellular Carcinoma)
  • DATE:Monday
  • TIME:10:30-12:00 PM
  • John Leyendecker MD - Nothing to disclose.
  • Moderator
  • Claude Sirlin MD - Research Grant, Bayer AGResearch Grant, General Electric CompanyResearch Grant, Bracco GroupContract, Isis Pharmaceuticals, IncContract, Pfizer IncSpeakers Bureau, Bayer AGConsultant, Bayer AGMedical Advisory Board, Bayer AGConsultant, Merck & Co, IncMedical Advisory Board, General Electric Company
  • Moderator
  •   Gastrointestinal Radiology
  •   Magnetic Resonance Imaging
  •   Oncologic Imaging
  • AMA PRA Category 1 Credits™: 1.5
  • ARRT Category A+ Credit: 1.5
  • Gastrointestinal Radiology
  • Magnetic Resonance Imaging
  • Oncologic Imaging
  • Virtual Meeting

SSC06-01  Was This HCC Able to Be Seen on Previous Gadoxetic Acid-enhanced MR Images? A Retrospective Review of Previous MR Images in Patients with Hypervascular HCC
SSC06-02  Imaging Phenotypes of Hepatocellular Carcinoma on Gadoxetic Acid Enhanced MR Imaging and Their Value as an Imaging Biomarker
SSC06-03  Detection of Hepatocellular Carcinomas: Angiographic CT (CTAP/CTHA) vs Gadoxetate Disodium-enhanced MRI
SSC06-04  Inter-Reader and Inter-Modality Agreement in the Depiction of the Diagnostic Vascularity Pattern in Hepatocellular Carcinoma Nodules ≤ 2 cm in Diameter
SSC06-05  Recommended Iodine Dose for Hepatic Arterial-dominant Phase CT Images of the Liver for Visualizing Hypervascular Hepatocellular Carcinoma (HCC): Multicenter Prospective Study in 91 Community Hospitals in Japan
SSC06-06  Evaluation of a Method for Improving Detection of Hepatocellular Carcinoma (HCC)
SSC06-07  Prediction of Short-Term Treatment Response after Selective Internal Radiotherapy of Liver Malignancy: Preliminary Experience with CT Perfusion
SSC06-08  Advanced Hepatocellular Carcinoma Treated with Sorafenib: Early Detection of Treatment Response and Major Adverse by Dynamic Contrast Enhanced Ultrasound
SSC06-09  Imaging Findings of Liver Parenchyma after Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: Evaluation by Gadoxetate Disodium-enhanced Hepatic MRI

No published email address listed.